Contact Information
Company Information
Annual Revenue
10332000.0
Technologies
Outlook
Microsoft Office 365
Google Tag Manager
Mobile Friendly
Adobe Media Optimizer
WordPress.org
Cedexis Radar
Vimeo
Apache
Viewpoint
Keywords
biotechnology
life sciences
immunotherapy
cancer treatment
personalized vaccines
oncology
genetic engineering
tg4050
tg4001
tg6050
bt-001
myvac platform
invir.io platform
oncolytic viruses
ai in medicine
clinical trials
immune response
anticancer therapy
hpv-related cancer
tumor-targeted treatment
solid tumors
virus-based therapies
therapeutic vaccines
immune checkpoint inhibitors
cytokines
interleukin 12
anti-ctla4
viral vectors
clinical efficacy
patient-specific treatment
cancer immunology
drug safety
therapeutic antibodies
tumor microenvironment
tumor regression
antigen-specific responses
viral oncolytics
neoadjuvant therapy
macrophage polarization
cancer vaccines
cancer research
therapeutic approaches
cancer immunotherapy
biological products
adjuvant therapy
molecular engineering
therapeutic modalities
clinical efficacy studies
neoadjuvant immunotherapy
cancer vaccine development
viral vector technology
individualized neoantigen vaccines
precision medicine
clinical-stage
personalized immunotherapy
drug development
cancer patients
biopharmaceutical partnerships
advanced cancer care
viral vector engineering
therapeutic candidates
healthcare providers
patient-specific treatments
innovative therapies
immune system stimulation
unmet medical needs
environmental responsibility
corporate social responsibility
strategic collaborations
ai-driven neoantigen prediction
euronext paris
hospital & health care
health care
health
wellness & fitness
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans